BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31316164)

  • 1. Silencing RORγt in Human CD4
    Shi X; Song P; Tao S; Zhang X; Chu CQ
    Sci Rep; 2019 Jul; 9(1):10375. PubMed ID: 31316164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cells.
    Song P; Chou YK; Zhang X; Meza-Romero R; Yomogida K; Benedek G; Chu CQ
    Biochem Biophys Res Commun; 2014 Oct; 452(4):1040-5. PubMed ID: 25241192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
    Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant suppression of T
    Na H; Lim H; Choi G; Kim BK; Kim SH; Chang YS; Nurieva R; Dong C; Chang SH; Chung Y
    J Allergy Clin Immunol; 2018 Jun; 141(6):2061-2073.e5. PubMed ID: 28943467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Th17 Cells with Small Molecules and Small Interference RNA.
    Lin H; Song P; Zhao Y; Xue LJ; Liu Y; Chu CQ
    Mediators Inflamm; 2015; 2015():290657. PubMed ID: 26792955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses.
    Ecoeur F; Weiss J; Kaupmann K; Hintermann S; Orain D; Guntermann C
    Front Immunol; 2019; 10():577. PubMed ID: 30972071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells.
    Cornelissen F; Mus AM; Asmawidjaja PS; van Hamburg JP; Tocker J; Lubberts E
    Arthritis Res Ther; 2009; 11(6):R194. PubMed ID: 20017902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
    Su CC; Lin HC; Lin YP; Shan YS; Yang BC
    Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds.
    Ding Q; Zhao M; Bai C; Yu B; Huang Z
    BMC Immunol; 2015 May; 16():32. PubMed ID: 26021566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor γt (RORγt) in Th17 cells.
    Han L; Yang J; Wang X; Wu Q; Yin S; Li Z; Zhang J; Xing Y; Chen Z; Tsun A; Li D; Piccioni M; Zhang Y; Guo Q; Jiang L; Bao L; Lv L; Li B
    J Biol Chem; 2014 Sep; 289(37):25546-55. PubMed ID: 25070893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RORγt and RORα signature genes in human Th17 cells.
    Castro G; Liu X; Ngo K; De Leon-Tabaldo A; Zhao S; Luna-Roman R; Yu J; Cao T; Kuhn R; Wilkinson P; Herman K; Nelen MI; Blevitt J; Xue X; Fourie A; Fung-Leung WP
    PLoS One; 2017; 12(8):e0181868. PubMed ID: 28763457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer.
    Chellappa S; Hugenschmidt H; Hagness M; Subramani S; Melum E; Line PD; Labori KJ; Wiedswang G; Taskén K; Aandahl EM
    J Immunol; 2017 Feb; 198(4):1729-1739. PubMed ID: 28053236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-bet represses collagen-induced arthritis by suppressing Th17 lineage commitment through inhibition of RORγt expression and function.
    Shimizu M; Kondo Y; Tanimura R; Furuyama K; Yokosawa M; Asashima H; Tsuboi H; Matsumoto I; Sumida T
    Sci Rep; 2021 Aug; 11(1):17357. PubMed ID: 34462459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation.
    Tan J; Liu H; Huang M; Li N; Tang S; Meng J; Tang S; Zhou H; Kijlstra A; Yang P; Hou S
    Cell Death Dis; 2020 Aug; 11(8):697. PubMed ID: 32829384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
    Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
    Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tetraazacyclic Compounds as Novel Potent Inhibitors Antagonizing RORγt Activity and Suppressing Th17 Cell Differentiation.
    Ding Q; Zhao M; Yu B; Bai C; Huang Z
    PLoS One; 2015; 10(9):e0137711. PubMed ID: 26368822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.